Amgen Inc.’s _______. Epogen. Commercializing the First Biotech Blockbuster drug Presented by: Faryn Kapala October 26 th , 2010. Brief History of Key Players What is Epogen ? Uses? Who Discovered Epogen ? How did they protect their IP? 3 types of patents
Commercializing the First Biotech Blockbuster drug
October 26th, 2010
was done through collaborations with UCLA and CIT.
Mimics a naturally occurring hormone erythropoietin
Produced in the kidneys
Stimulates the production of RBC’s by the bone marrow
RBC’s carry oxygen around
Nobody ever made the product before
Prior Art: Publications, other patents
Ex.) Pencil & Eraser
It has to somehow be useful
“transmitting vocal sounds telegraphically by using electrical undulations”
*His invention: Electromagnetism*Better invention: Variable Resistance
Dividing line between Product & Process is vague
1.) Product Patent Denied!
Epogen had already been patented!
2.) Process Patent Denied!
This one was expected based on recent biotech laws…
3.) Starting Materials Granted!
Genetics Institute had not proved that it had isolated a protein with the biological characteristics described in the patent. As a result, Genetics Institute's claims were invalid.
See Ch.2 – Page 65 in YOUR MIS BOOK!
C.) Represented in each division of a large company but under central control